NutriBand Inc.
Nutriband (Nasdaq: NTRB) develops transdermal pharmaceutical products, with its pipeline focused primarily on AVERSA™, a proprietary technology designed to deter abuse, misuse and accidental exposure from drug-containing patches. Its lead candidate, AVERSA™ Fentanyl, combines an approved generic fentanyl patch with… From the company’s description.
Over the twelve months to Jul 31, 2026, NutriBand Inc. reported revenue of $1.62M, down 37.3% from a year earlier, and a net loss of $6.96M. Its operating margin was −435.5%, and operations used $3.63M in cash. In fiscal 2025, it reported revenue of $2.04M, down 4.8% from fiscal 2024, and a net loss of $8.23M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What NutriBand Inc. does
In the company’s own words
Nutriband (Nasdaq: NTRB) develops transdermal pharmaceutical products, with its pipeline focused primarily on AVERSA™, a proprietary technology designed to deter abuse, misuse and accidental exposure from drug-containing patches. Its lead candidate, AVERSA™ Fentanyl, combines an approved generic fentanyl patch with aversive agents; other pipeline candidates include AVERSA™ Buprenorphine and AVERSA™ Methylphenidate. The company also evaluates transdermal delivery of approved drugs and biologics typically given by injection. Its two operating subsidiaries provide services: Pocono Pharmaceuticals, operating as Active Intelligence, manufactures products for health, wellness and over-the-counter pharmaceutical customers, while 4P Therapeutics provides research and development services to pharmaceutical and medical-device customers. Nutriband acquired 4P Therapeutics in 2018, shifting its focus toward pharmaceutical transdermal products, and acquired the transdermal, topical, cosmetic and nutraceutical business of Pocono Coated Products in 2020. It primarily operates and earns revenue in the United States. Its website is www.nutriband.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- ORLANDO, FL
- Fiscal year end
- January
- CIK
- 1676047
- SIC
- 3842
Financial performance, year by year
Fiscal 2016–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns NutriBand Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · NutriBand Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do NutriBand Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of NutriBand Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in NutriBand Inc.'s last four quarterly filings that the numbers alone won't show?”